439 related articles for article (PubMed ID: 29199513)
1. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
2. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
3. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
4. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
6. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration.
Stich O; Graus F; Rasiah C; Rauer S
J Neuroimmunol; 2003 Aug; 141(1-2):165-9. PubMed ID: 12965268
[TBL] [Abstract][Full Text] [Related]
7. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
8. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
[TBL] [Abstract][Full Text] [Related]
9. Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.
Herdlevaer I; Kråkenes T; Schubert M; Vedeler CA
Ann Clin Transl Neurol; 2020 Nov; 7(11):2231-2242. PubMed ID: 33009713
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
12. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
13. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
14. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome.
Thakolwiboon S; Linnoila J; Pittock SJ; Dubey D; Zekeridou A
J Neuroimmunol; 2024 Feb; 387():578293. PubMed ID: 38266443
[TBL] [Abstract][Full Text] [Related]
17. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
Phuphanich S; Brock C
J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
[TBL] [Abstract][Full Text] [Related]
18. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
19. CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.
Kråkenes T; Herdlevaer I; Raspotnig M; Haugen M; Schubert M; Vedeler CA
Ann Neurol; 2019 Aug; 86(2):316-321. PubMed ID: 31148214
[TBL] [Abstract][Full Text] [Related]
20. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.
Greenlee JE; Clawson SA; Hill KE; Wood BL; Tsunoda I; Carlson NG
J Neuropathol Exp Neurol; 2010 Oct; 69(10):997-1007. PubMed ID: 20838245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]